Safety and Efficacy of Formulation for Improving Vagina Laxity: A Pilot Study

Launched by UNGKU SHAHRIN MEDICAL AESTHETIC RESEARCH & INNOVATION (USMARI) CENTRE · Jan 24, 2023

Keywords

ClinConnect Summary

This clinical trial is exploring a new treatment aimed at improving a condition known as vaginal laxity (VL) in women. Specifically, it is testing a formulation made from natural ingredients, including stem cell secretome and licorice root extract, which may help rejuvenate and renew cells in the vaginal area. The study will last for 5 weeks, during which researchers will evaluate the effectiveness of the treatment and check for any side effects.

To participate, women must be between 40 and 55 years old, living in Malaysia, and experiencing vaginal laxity. However, pregnant or breastfeeding women, as well as those who have recently undergone certain procedures for vaginal laxity, are not eligible to join. Participants can expect assessments at the beginning of the study, at 2 weeks, and again at 5 weeks to track any changes. This trial is currently recruiting volunteers who are willing to help advance our understanding of this condition.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Malaysian women ( age 40 to 55 years old)
• • Complaint of vagina laxity
• • Willingness to participate in the study
• Exclusion Criteria:
• • Pregnant and breastfeeding women
• • Doing any surgical or non-surgical procedures to improved vaginal laxity condition such as laser and radiofrequency before participating in the study that might affect the study outcome
• • Presence of illness or taking any medication that might impact the study outcome or participants well-being